No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and hispanics

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 1113-1115

  Lehrer, Steven ^a   Green, Sheryl ^a   Ramanathan, Lakshmi ^a   Rosenzweig, Kenneth ^a   Labombardi, Vincent ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cytomegalovirus; Glioblastoma; Malignant brain tumor; Seropositivity; Seroprevalence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GLIOBLASTOMA; HISPANIC; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEROPREVALENCE; SEX DIFFERENCE; VIRUS DETECTION;

AFRICAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GLIOBLASTOMA; HISPANIC AMERICANS; HUMANS; INCIDENCE; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 84858778444     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bate SL, Dollard SC and Cannon MJ: Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004. Clinical Infectious Diseases 50: 1439-1447, 2010.
2. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2000-2004. pp. 1-57. 2008. Hinsdale, Illinois, Central Brain Tumor Registry of the United States.
3. Chakrabarti I, Cockburn M, Cozen W, Wang YP, and Preston-Martin S: A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer 104: 2798-2806, 2005. (Pubitemid 41798291)
4. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG and Britt WJ: Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62: 3347-3350, 2002. (Pubitemid 34651375)
5. Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM and Rosenzweig KE: No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31: 959-960, 2011.
6. Miller G: Brain cancer. A viral link to glioblastoma? Science 323: 30-31, 2009.
7. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, and Sampson JH: Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10: 10-18, 2008. (Pubitemid 351250896)
8. Prins RM, Cloughesy TF and Liau LM: Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. New England Journal of Medicine 359: 539-541, 2008.
9. Strandberg TE, Pitkala KH and Tilvis RS: Cytomegalovirus Antibody Level and Mortality Among Community-Dwelling Older Adults With Stable Cardiovascular Disease. JAMA: The Journal of the American Medical Association 301: 380-382, 2009.
10. Wen PY and Kesari S: Malignant Gliomas in Adults. The New England Journal of Medicine 359: 492-507, 2008.
11. Wigertz A, Lonn S, Hall P and Feychting M: Non-participant characteristics and the association between socioeconomic factors and brain tumour risk. J Epidemiol Community Health 64: 736-743, 2010.